MedPath

The MOTION Study - Treatment of LSS With the MILD Procedure

Not Applicable
Active, not recruiting
Conditions
Spinal Stenosis, Lumbar Region, With Neurogenic Claudication
Interventions
Device: MILD Procedure
Other: Conventional Medical Management (CMM)
Registration Number
NCT03610737
Lead Sponsor
Vertos Medical, Inc.
Brief Summary

Prospective, multicenter, randomized controlled clinical study examining functional improvement in lumbar spinal stenosis (LSS) patients with neurogenic claudication who are treated with the MILD procedure plus conventional medical management (CMM) compared to those treated with CMM alone, as the control. Subjects in the control group are able to crossover and receive MILD after completion of 12-month follow-up. The study will provide objective functional improvement data for patients treated with the mild Procedure as first-line therapy in a real-world setting.

Detailed Description

The study will follow participants treated in the MILD plus CMM group and crossover participants for up to 5 years on annual bases.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
155
Inclusion Criteria
  • Patients experiencing neurogenic claudication symptoms for at least 3 months duration.
  • LSS with neurogenic claudication
  • Radiologic evidence of LSS with unilateral or bilateral ligamentum flavum ≥ 2.5mm confirmed by pre-op MRI or CT performed within 12 months of baseline visit.
  • Patients with comorbid conditions commonly associated with spinal stenosis, such as osteophytes, facet hypertrophy, minor spondylolisthesis (Grade I without instability), foraminal stenosis, and/or disk protrusion may be included unless the treating physician has determined that the condition is too advanced.
  • Stable opioid intake with no change during 30 days prior to enrollment.
  • Available to complete all follow-up visits.
Exclusion Criteria
  • ODI Score < 31 (0-100 ODI Scale).
  • NPRS Score < 5 (0-10 NPRS Scale).
  • Lumbar epidural injections during eight weeks prior to study enrollment.
  • Baseline analgesic medication greater than 90 milligram morphine equivalent (MME).
  • Prior surgery at the same treatment level.
  • Previously received interspinous spacer at the same treatment level.
  • Previously received intradiscal procedure at the same treatment level.
  • Previously received vertebral augmentation procedure at the same treatment level.
  • Previously received the MILD procedure at the same treatment level.
  • Received radiofrequency ablation at the same or the adjacent levels within 6 months prior to study enrollment.
  • History of spinal fractures with current related pain symptoms.
  • Grade II or higher spondylolisthesis.
  • Motor deficit or disabling back and/or leg pain from causes other than LSS neurogenic claudication (e.g. acute compression fracture, metabolic neuropathy, or vascular claudication symptoms, etc.).
  • Unable to walk ≥ 10 feet unaided before being limited by pain. In this context, 'unaided' means without the use of a cane, walker, railing, wall, another person or any other means of walking assistance.
  • Previously randomized and/or treated in this clinical study.
  • Epidural lipomatosis (if it is deemed to be a significant contributor of canal narrowing by the physician).
  • On (or pending) Workman's Compensation or known to be considering litigation associated with back pain.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MILD with CMMMILD ProcedureThe MILD procedure is an image-guided minimally-invasive lumbar decompression with conventional medical managment
MILD with CMMConventional Medical Management (CMM)The MILD procedure is an image-guided minimally-invasive lumbar decompression with conventional medical managment
CMM aloneConventional Medical Management (CMM)Patient in the CMM alone group can have physical therapy, home exercise, pain medication, epidural steroid injections, nerve blocks, and other lumbar steroid injections.
Primary Outcome Measures
NameTimeMethod
Mean Change in Oswestry Disability Index (ODI)Mean Change in Oswestry Disability Index (ODI) baseline to 12 month

Oswestry Disability Index (ODI) is a widely-used validated questionnaire use to measure a patient's functional disability. The total score ranges from 0 (no disability) - 100 (complete disability). Score categories: 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), 81-100 (bed bound or have an exaggerating).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (18)

Kansas Pain Management

🇺🇸

Overland Park, Kansas, United States

Interventional Pain Management Specialists

🇺🇸

Overland Park, Kansas, United States

The Center for Pain Relief

🇺🇸

Charleston, West Virginia, United States

Center for Pain Management

🇺🇸

Hackensack, New Jersey, United States

Newport Heache & Pain

🇺🇸

Newport Beach, California, United States

The Pain Management and Rehabilitation Center

🇺🇸

Seymour, Indiana, United States

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

Centura Spine Center

🇺🇸

Colorado Springs, Colorado, United States

Spine & Pain Institute of Florida

🇺🇸

Lakeland, Florida, United States

SIMED

🇺🇸

Ocala, Florida, United States

MI Interventional Pain Center

🇺🇸

Brownstown, Michigan, United States

Michigan Pain Specialists

🇺🇸

Ypsilanti, Michigan, United States

Roanoke-Chowan Pain Management

🇺🇸

Ahoskie, North Carolina, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Pennsylvania Pain & Spine Institute

🇺🇸

Chalfont, Pennsylvania, United States

Precision Spin Care

🇺🇸

Tyler, Texas, United States

UH St. John Pain Management Center

🇺🇸

Westlake, Ohio, United States

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath